Results 161 to 170 of about 6,040 (212)
Some of the next articles are maybe not open access.
Rimonabant—A Selective CB1 Antagonist
Annals of Pharmacotherapy, 2005 OBJECTIVE: To review the pharmacology, pharmacokinetics, clinical efficacy, and safety of rimonabant, a new selective cannabinoid receptor antagonist. DATA SOURCES: Primary literature and review articles were obtained via a MEDLINE ...Steven Thomas, Boyd, Brad Allen, Fremming +1 moreexaly +3 more sourcesRimonabant
Drugs, 2006 Rimonabant is the first of a new class of selective cannabinoid receptor-1 blockers. It reduces the overactivity of the endocannabinoid system, improving lipid and glucose metabolism and regulating food intake and energy balance. In four randomised, double-blind clinical trials in overweight or obese adults with or without type 2 diabetes and/or ...Sheridan, Henness, Dean M, Robinson, Katherine A, Lyseng-Williamson +2 more +6 more sourcesRimonabant for overweight or obesity
Cochrane Database of Systematic Reviews, 2006 Worldwide, the prevalence of obesity and overweight in industrialized countries and in a substantial number of developing countries is increasing at an alarming rate. Rimonabant is a selective cannabinoid-1 receptor antagonist that has been investigated for its efficacy in reducing body weight and associated risk factors in obese people.C, Curioni, C, Andréopenaire +2 more sourcesRimonabant
Reactions Weekly, 2010 Stan Floresco, Robert Kessler, Ronald L. Cowan, Robert Kessler, Ronald L. Cowan, Mark Slifstein, Andrea Cipriani, John Geddes, Tooru M. Mizuno, Seithikurippu R. Pandi-Perumal, Milton Kramer, Michael J. Thorpy, Shelby Freedman Harris, D. Warren Spence, Harriet de Wit, Galen R. Wenger, David V. Sheehan, Kathy H. Sheehan, Peter Riederer, Siegfried Hoyer, Klaus A. Miczek, Christoph Hiemke, Luis Stinus, Stéphanie Caillé, Martine Cador, Susan Jones, Josee E. Leysen, Xavier Langlois, Lieve Heylen, Adriaan A. Lammertsma, Hilde Lavreysen, John Atack, Arthur Christopoulos, Gregory D. Stewart, Patrick M. Sexton, Iván Izquierdo, Lia R. Bevilaqua, Martin Cammarota, Lukas Pezawas, Francis C. Colpaert, Mischa de Rover, Sander Nieuwenhuis, Sarah H. Heil, Stacey C. Sigmon, Stephen T. Higgins, Roy Wise, Paul B. S. Clarke, Mary E. Cain, Michael T. Bardo, Sunila G. Nair, Yavin Shaham, Yavin Shaham, John R. Mantsch, Alan J. Budney, David S. Baldwin, Ashwini Padhi, Naomi A. Fineberg, Helen J. Cassaday, Michael M. Morgan, MacDonald J. Christie, Seithikurippu R. Pandi-Perumal, Milton Kramer, Michael J. Thorpy, Shelby Freedman Harris, D. Warren Spence, Stephen M. Stahl, Meghan M. Grady, Stephen M. Stahl, Warren H. Meck, Catalin V. Buhusi, Thomas Steckler, Ennio Esposito, Roberto William Invernizzi, Matthew I. Palmatier, Rick A. Bevins, Francis C. Colpaert, Francis C. Colpaert, Craig A. Erickson, David J. Posey, Kelly Blankenship, Kimberly A. Stigler, Christopher J. McDougle, Mark Slifstein, Giovanni Hernandez, Peter Shizgal, Michael J. Kuhar, Tomek J. Banasikowski, Richard J. Beninger, Sara Tomlinson, Glen B. Baker, Stephen C. Fowler, Peter J. Flor, Inga D. Neumann, Joseph H. Friedman, Britta Hahn, Bernard Le Foll, Grasielle C. Kincheski, Leandro J. Bertoglio, Antonio Pádua Carobrez, Suzanne H. Mitchell, Harriet de Wit, Marie-Louise G. Wadenberg, Marlene Dobkin de Rios, Charles S. Grob, Theodora Duka, Linda Lundström, Silvia Gatti McArthur, Will Spooren, Peter J. Flor, Inga D. Neumann, Trevor W. Robbins, Jos Prickaerts, Harriet de Wit, Harriet de Wit, Peter H. Boeijinga, Yavin Shaham, Sunila G. Nair +116 more +5 more sources
